Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.
FDA orders “limited distribution” for lung cancer drug Iressa.
House approves $210 million for Dept. of Defense cancer research programs.
House Committee on Appropriations approves $28.5 billion for NIH.
House panel investigating NIH handling of tissue specimens.
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- What are you reading in 2023?
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence